Market Closed -
Hong Kong S.E.
04:08:06 2024-04-30 am EDT
|
5-day change
|
1st Jan Change
|
0.9
HKD
|
+8.43%
|
|
+8.43%
|
+5.88%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
561.1
|
480.1
|
395.7
|
109.1
|
96.8
|
176.5
|
Enterprise Value (EV)
1 |
623.4
|
572.7
|
482.6
|
127.3
|
202.6
|
-9.581
|
P/E ratio
|
6.75
x
|
15.4
x
|
11.5
x
|
24.3
x
|
4.7
x
|
3.29
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
3.83%
|
Capitalization / Revenue
|
0.71
x
|
0.56
x
|
0.54
x
|
0.18
x
|
0.13
x
|
0.37
x
|
EV / Revenue
|
0.79
x
|
0.67
x
|
0.66
x
|
0.21
x
|
0.27
x
|
-0.02
x
|
EV / EBITDA
|
5.52
x
|
10.3
x
|
10.5
x
|
13.2
x
|
6.39
x
|
1.51
x
|
EV / FCF
|
-5.56
x
|
-20.4
x
|
377
x
|
0.82
x
|
-5.64
x
|
-0.1
x
|
FCF Yield
|
-18%
|
-4.91%
|
0.27%
|
122%
|
-17.7%
|
-1,043%
|
Price to Book
|
0.81
x
|
0.67
x
|
0.52
x
|
0.14
x
|
0.12
x
|
0.21
x
|
Nbr of stocks (in thousands)
|
135,000
|
135,000
|
135,000
|
135,000
|
135,000
|
135,000
|
Reference price
2 |
4.156
|
3.556
|
2.931
|
0.8080
|
0.7170
|
1.307
|
Announcement Date
|
4/26/18
|
4/15/19
|
5/11/20
|
4/28/21
|
4/27/22
|
4/28/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
792.2
|
858.8
|
726.6
|
607.1
|
763.2
|
472.5
|
EBITDA
1 |
112.9
|
55.74
|
46.17
|
9.656
|
31.73
|
-6.35
|
EBIT
1 |
106.4
|
48.97
|
40.94
|
3.884
|
26.07
|
-12.12
|
Operating Margin
|
13.44%
|
5.7%
|
5.63%
|
0.64%
|
3.42%
|
-2.57%
|
Earnings before Tax (EBT)
1 |
114.5
|
46.41
|
45.11
|
0.503
|
25.72
|
75.77
|
Net income
1 |
83.16
|
31.24
|
34.29
|
4.489
|
20.61
|
53.6
|
Net margin
|
10.5%
|
3.64%
|
4.72%
|
0.74%
|
2.7%
|
11.35%
|
EPS
2 |
0.6160
|
0.2314
|
0.2540
|
0.0333
|
0.1527
|
0.3971
|
Free Cash Flow
1 |
-112.2
|
-28.13
|
1.28
|
155.8
|
-35.89
|
99.92
|
FCF margin
|
-14.16%
|
-3.27%
|
0.18%
|
25.67%
|
-4.7%
|
21.15%
|
FCF Conversion (EBITDA)
|
-
|
-
|
2.77%
|
1,613.63%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
3.73%
|
3,470.98%
|
-
|
186.4%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
0.0500
|
Announcement Date
|
4/26/18
|
4/15/19
|
5/11/20
|
4/28/21
|
4/27/22
|
4/28/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
62.3
|
92.6
|
86.9
|
18.3
|
106
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
186
|
Leverage (Debt/EBITDA)
|
0.5517
x
|
1.661
x
|
1.882
x
|
1.891
x
|
3.334
x
|
-
|
Free Cash Flow
1 |
-112
|
-28.1
|
1.28
|
156
|
-35.9
|
99.9
|
ROE (net income / shareholders' equity)
|
12.8%
|
4.43%
|
4.64%
|
0.59%
|
2.68%
|
6.64%
|
ROA (Net income/ Total Assets)
|
3.99%
|
1.95%
|
1.65%
|
0.16%
|
1.05%
|
-0.48%
|
Assets
1 |
2,082
|
1,604
|
2,079
|
2,867
|
1,954
|
-11,055
|
Book Value Per Share
2 |
5.110
|
5.340
|
5.600
|
5.630
|
5.780
|
6.180
|
Cash Flow per Share
2 |
0.3500
|
0.1200
|
0.2900
|
0.7700
|
0.0700
|
1.790
|
Capex
1 |
53.4
|
1.48
|
1.1
|
0.69
|
19.7
|
5.53
|
Capex / Sales
|
6.74%
|
0.17%
|
0.15%
|
0.11%
|
2.58%
|
1.17%
|
Announcement Date
|
4/26/18
|
4/15/19
|
5/11/20
|
4/28/21
|
4/27/22
|
4/28/23
|
|
1st Jan change
|
Capi.
|
---|
| +5.88% | 15.53M | | +10.48% | 8.69B | | +27.40% | 2.14B | | -7.53% | 1.09B | | +6.61% | 754M | | +1.15% | 837M | | -11.56% | 624M | | +6.30% | 610M | | -4.66% | 577M | | +2.70% | 594M |
Purification & Treatment Equipment
|